1. Latest News
  2. Submit Press Release

Mr. Alon Maor Joined Ultrashape Board of Directors as Active Vice Chairman

Alon is an industry veteran with over 20 years of experience in Medical Devices.

 
PRLog - June 2, 2011 - Effective   immediately, Alon Maor will join Ultrashape’s Board of Directors as Active Vice Chairman. Alon is an industry veteran with over 20 years of experience in Medical Devices.   Alon founded Lumenis Japan and was later appointed CEO of the entire Asia Pacific region. Following his considerable success in the APAC region, Alon was appointed Executive Vice President and General Manager of the global Aesthetic Business Unit. In 2004 Alon co-founded and became CEO of Aesthera Corporation, a Kleiner Perkins backed Aesthetic device innovator which was acquired by Solta Medical in 2010.
“We are delighted that Alon has agreed to join our board. We see it as a show of confidence in the future of Ultrashape” said Assaf Eyal CEO and President of Ultrashape. “Alon will help the board and management create and execute a long term strategic growth plan”.
“I am very excited to join the Ultrashape board” said Alon. “The growth potential in the Non-Invasive Body Contouring segment is vast and the company is well positioned to take advantage of it with its innovative technology”.  “I see several growth engines both organic and non organic from which the company can benefit going forward” he added.
------------------------------------------------------------------------
About UltraShape
UltraShape redefines aesthetic medicine by developing, manufacturing and marketing innovative non-invasive technologies for fat cell destruction and body sculpting. The company develops and markets clinically proven safe and effective solutions that enhance the lives of patients. The UltraShape proprietary technology employs pulsed (non-thermal) focused ultrasound that instantly, selectively and permanently destroys fat cells without affecting surrounding structures. Founded in 2000, UltraShape has sold Contour I devices in more than 50 countries, demonstrating safety and efficacy.
The UltraShape Contour I system, is authorized for marketing outside the U.S. It is the first clinically proven non-invasive solution that offers measurable lasting body sculpting results for men and women with no need for maintenance treatments. The UltraShape system has been shown to be safe and effective in a multi-center controlled trial and numerous other peer-reviewed published independent clinical studies.
Contact:
Tal Fishman
Kwan Communications
+972 50 460 0140

--- End ---

Click to Share

Contact Email:
***@ultrashape.com Email Verified
Source:UltraShape
Industry:Health, Beauty, Fitness
Tags:body sculpting, fat loss, Focused Ultrasound, body contouring, fat reduction, liposuction, fat cell destruction
Shortcut:prlog.org/11522232
Verified Account Email Address

Disclaimer:   Issuers of the press releases are solely responsible for the content of their press releases. PRLog can't be held liable for the content posted by others.   Report Abuse

Trending News...



Like PRLog?
9K2K1K
Click to Share